S&P 500 7,675.99 +0.69%
Nasdaq 26,197.59 +0.93%
S&P/TSX 35,968.39 +0.50%
Apple 344.28 −0.99%
Nvidia 215.44 +2.12%
Microsoft 530.04 +1.05%
Shopify 237.23 +0.42%
Royal Bank 283.29 +0.54%
CAD/USD 0.7133 −0.12%
LIVE · 12:40 ET
Market ClerkRecap
Mon Oct 26 · markets open1 signal today94 insider buys this week · $48.3MCIRO short report next: Oct 31The week ahead
RL
INSIDER · MGX · Metagenomi Therapeutics, Inc. · DIRECTOR

Reid Laurence

Every open-market transaction filed under this name, Sep 9 to Sep 9.

Filings
1
1 buy · 0 sells
Bought
$23K
open market, at cost
Sold
—
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 9MGXMetagenomi Therapeutics, Inc.DirectorBuy19,883$1.17$23K—

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.